MEDIROM Healthcare Technologies Inc.
MRMNASDAQConsumer Cyclical● Active
$1.13
+$0.00(+0.00%)
Market Cap$5771367
P/E Ratio—
52W High$4.45
52W Low$0.9
MEDIROM Healthcare Technologies Inc. (MRM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MRM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.05
Revenue
$0.00B
Est. $0.00B · +0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
MRM reports quarterly as a NASDAQ-listed Personal Products & Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 5, 2026 | — | $0.05 | — | $0.00B | $0.00B | +0.0% |
| — Q2 FY2025 | Apr 29, 2025 | — | $0.79 | — | $0.03B | — | — |
| — Q2 FY2024 | Jun 30, 2024 | — | -$0.74 | — | $0.02B | — | — |
| — Q2 FY2024 | Jun 18, 2024 | — | $0.62 | — | $0.03B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | -$0.50 | — | $0.02B | — | — |
| — Q2 FY2023 | May 30, 2023 | — | $0.42 | — | $0.03B | — | — |
| — Q2 FY2022 | Jun 30, 2022 | — | -$0.14 | — | $0.01B | — | — |
| — Q2 FY2022 | May 16, 2022 | — | -$0.42 | — | $0.01B | — | — |
Q2 FY2026
May 5, 2026
EPS Actual
$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Apr 29, 2025
EPS Actual
$0.79
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q2 FY2024
Jun 30, 2024
EPS Actual
-$0.74
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q2 FY2024
Jun 18, 2024
EPS Actual
$0.62
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q2 FY2023
Jun 30, 2023
EPS Actual
-$0.50
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q2 FY2023
May 30, 2023
EPS Actual
$0.42
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q2 FY2022
Jun 30, 2022
EPS Actual
-$0.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2022
May 16, 2022
EPS Actual
-$0.42
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.6B | $0.6B | $0.6B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 5, 2026 | — | $1.22 | $1.20 | -1.64% |
| — Q2 FY2025 | Apr 29, 2025 | — | $0.70 | $0.70 | +0.00% |
| — Q2 FY2024 | Jun 30, 2024 | — | $3.92 | $4.21 | +7.40% |
| — Q2 FY2024 | Jun 18, 2024 | — | $5.08 | $4.98 | -1.97% |
| — Q2 FY2023 | Jun 30, 2023 | — | $5.45 | $5.43 | -0.37% |
| — Q2 FY2023 | May 30, 2023 | — | $5.95 | $5.98 | +0.50% |
| — Q2 FY2022 | Jun 30, 2022 | — | $6.20 | $5.98 | -3.55% |
| — Q2 FY2022 | May 16, 2022 | — | $7.41 | $7.97 | +7.56% |
Q2 FY2026-1.64%
Report Date
May 5, 2026
EPS Beat/Miss
—
Price Before
$1.22
Price After
$1.20
Q2 FY2025+0.00%
Report Date
Apr 29, 2025
EPS Beat/Miss
—
Price Before
$0.70
Price After
$0.70
Q2 FY2024+7.40%
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$3.92
Price After
$4.21
Q2 FY2024-1.97%
Report Date
Jun 18, 2024
EPS Beat/Miss
—
Price Before
$5.08
Price After
$4.98
Q2 FY2023-0.37%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$5.45
Price After
$5.43
Q2 FY2023+0.50%
Report Date
May 30, 2023
EPS Beat/Miss
—
Price Before
$5.95
Price After
$5.98
Q2 FY2022-3.55%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$6.20
Price After
$5.98
Q2 FY2022+7.56%
Report Date
May 16, 2022
EPS Beat/Miss
—
Price Before
$7.41
Price After
$7.97
Beat Rate0 / 8 quarters
Largest Move+7.56% (Q2 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MRM ends December
MEDIROM Healthcare Technologies Inc. (MRM) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.05 (in line with the analyst consensus of —). The next MRM earnings date is expected around September 1, 2026.
Each quarter, investors track MRM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MRM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MRM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MRM earnings · 4 questionsMEDIROM Healthcare Technologies Inc.'s next earnings report is expected around September 1, 2026. MRM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MRM historically reports after market close (AMC).
MRM earnings datewhen is MRM earningsMRM next earnings datewhen does MRM report earningsMRM earnings calendar
▸ Source: FMP · MEDIROM Healthcare Technologies Inc. SEC filings · US GAAP · MEDIROM Healthcare Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026